{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T22:32:21Z","timestamp":1787956341048,"version":"build-2784847793"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T00:00:00Z","timestamp":1487721600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007314","name":"Duncan Family Institute for Cancer Prevention and Risk Assessment","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007314","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Surviv"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s11764-017-0606-3","type":"journal-article","created":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T16:54:55Z","timestamp":1487782495000},"page":"477-485","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["A pilot randomized trial to prevent sexual dysfunction in postmenopausal breast cancer survivors starting adjuvant aromatase inhibitor therapy"],"prefix":"10.1007","volume":"11","author":[{"given":"Pragati","family":"Advani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abenaa M.","family":"Brewster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George P.","family":"Baum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie R.","family":"Schover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,22]]},"reference":[{"key":"606_CR1","doi-asserted-by":"crossref","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG), Dowsett M, Forbes JF, Bradley R, Ingle J, Aihara T, Bliss J, Boccardo F, Coates A, Coombes RC, Cuzick J, Dubsky P, Gnant M, Kaufmann M, Kilburn L, Perrone F, Rea D, Th\u00fcrlimann B, van de Velde C, Pan H, Peto R, Davies C, Gray R. Aromatase inhibitors versus tamoxifen in early breast cancer; patient-level meta-analysis of the randomised trials. Lancet. 2015; 386:1341\u20131352.","DOI":"10.1016\/S0140-6736(15)61074-1"},{"key":"606_CR2","doi-asserted-by":"crossref","unstructured":"Goss PE, Ingle JN, Pritchard KI, Robert NJ, Muss H, Gralow J, Gelmon K, Whelan T, Strasser-Weippl K, Rubin S, Sturtz K, Wolff AC, Winer E, Hudis C, Stopeck A, Beck JT, Kaur JS, Whelan K, Tu D, Parulekar WR. Extending aromatase-inhibitor adjuvant therapy to 10\u00a0years. N Eng J Med. 2016.","DOI":"10.1056\/NEJMoa1604700"},{"key":"606_CR3","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S1470-2045(15)00049-2","volume":"16","author":"J Bernhard","year":"2015","unstructured":"Bernhard J, Luo W, Ribi K, Colleoni M, Burstein HJ, Tondini C, Pinotti G, Spazzapan S, Ruhstaller T, Puglisi F, Pavesi L, Parmar V, Regan MM, Pagani O, Fleming GF, Francis PA, Price KN, Coates AS, Gelber RD, Goldhirsch A, Walley BA. Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials. Lancet Oncol. 2015;16:848\u201358.","journal-title":"Lancet Oncol"},{"key":"606_CR4","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1200\/JCO.2015.65.9573","volume":"34","author":"HJ Burstein","year":"2016","unstructured":"Burstein HJ, Lacchetti C, Anderson H, Buchholz TA, Davidson NE, Gelmon KE, Giordano SH, Hudis CA, Solky AJ, Stearns V, Winer EP, Griggs JJ. Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: American Society of Clinical Oncology Clinical Practice Guideline Update on ovarian suppression. J Clin Oncol. 2016;34:1689\u2013701.","journal-title":"J Clin Oncol"},{"key":"606_CR5","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/GME.0b013e31826560da","volume":"20","author":"J Baumgart","year":"2013","unstructured":"Baumgart J, Nilsson K, Evers AS, Kallak TK, Poromaa IS. Sexual dysfunction in women on adjuvant endocrine therapy after breast cancer. Menopause. 2013;20:162\u20138.","journal-title":"Menopause"},{"key":"606_CR6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3109\/13697137.2013.800039","volume":"17","author":"J Baumgart","year":"2014","unstructured":"Baumgart J, Nilsson K, Stavreus Evers A, Kunovac Kallak T, Kushnir MM, Bergquist J, Sundstr\u00f6m Poromaa I. Androgen levels during adjuvant endocrine therapy in postmenopausal breast cancer patients. Climacteric. 2014;17:48\u201354.","journal-title":"Climacteric"},{"key":"606_CR7","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.yhbeh.2015.11.003","volume":"78","author":"M Cappelletti","year":"2016","unstructured":"Cappelletti M, Wallen K. Increasing women\u2019s sexual desire: the comparative effectiveness of estrogens and androgens. Horm Behav. 2016;78:178\u201393.","journal-title":"Horm Behav"},{"key":"606_CR8","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1111\/jsm.12684","volume":"11","author":"LR Schover","year":"2014","unstructured":"Schover LR, Baum GP, Fuson LA, Brewster A, Melhem-Bertrandt A. Sexual problems during the first 2\u00a0years of adjuvant treatment with aromatase inhibitors. J Sex Med. 2014;11:3102\u201311.","journal-title":"J Sex Med"},{"key":"606_CR9","first-page":"B4814","volume":"57","author":"M Groenvold","year":"2010","unstructured":"Groenvold M. Health-related quality of life in early breast cancer. Dan Med Bull. 2010;57:B4814.","journal-title":"Dan Med Bull"},{"key":"606_CR10","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1200\/JCO.2015.64.3866","volume":"34","author":"PA Ganz","year":"2016","unstructured":"Ganz PA, Petersen L, Bower JE, Crespi CM. Impact of adjuvant endocrine therapy on quality of life and symptoms: observational data over 12\u00a0months from the mind-body study. J Clin Oncol. 2016;34:816\u201324.","journal-title":"J Clin Oncol"},{"key":"606_CR11","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1586\/erp.11.57","volume":"11","author":"Z Hamidou","year":"2011","unstructured":"Hamidou Z, Dabakuyo TS, Bonnetain F. Impact of response shift on longitudinal quality-of-life assessment in cancer clinical trials. Expert Rev Pharmacoecon Outcomes Res. 2011;11:549\u201359.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"606_CR12","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s10508-007-9290-0","volume":"38","author":"KE Lutfey","year":"2009","unstructured":"Lutfey KE, Link CL, Rosen RC, Wiegel M, McKinlay JB. Prevalence and correlates of sexual activity and function in women: results from the Boston Area Community Health (BACH) survey. Arch Sex Behav. 2009;38:514\u201327.","journal-title":"Arch Sex Behav"},{"key":"606_CR13","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1007\/s00520-014-2573-9","volume":"23","author":"J Carter","year":"2015","unstructured":"Carter J, Stabile C, Seidel B, Baser RE, Gunn AR, Chi S, Steed RF, Goldfarb S, Goldfrank DJ. Baseline characteristics and concerns of female cancer patients\/survivors seeking treatment at a female sexual medicine program. Support Care Cancer. 2015;23:2255\u201365.","journal-title":"Support Care Cancer"},{"key":"606_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00926230590475206","volume":"31","author":"M Wiegel","year":"2005","unstructured":"Wiegel M, Meston C, Rosen R. The Female Sexual Function Index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther. 2005;31:1\u201320.","journal-title":"J Sex Marital Ther."},{"key":"606_CR15","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1002\/cncr.26739","volume":"118","author":"RE Baser","year":"2012","unstructured":"Baser RE, Li Y, Carter J. Psychometric validation of the Female Sexual Function Index (FSFI) in cancer survivors. Cancer. 2012;118:4606\u201318.","journal-title":"Cancer"},{"key":"606_CR16","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1743-6109.2010.01988.x","volume":"8","author":"J Carter","year":"2011","unstructured":"Carter J, Goldfrank D, Schover LR. Simple strategies for vaginal health promotion in cancer survivors. J Sex Med. 2011;8:549\u201359.","journal-title":"J Sex Med"},{"key":"606_CR17","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.6004\/jnccn.2013.0162","volume":"11","author":"LR Schover","year":"2013","unstructured":"Schover LR, Yuan Y, Fellman BM, Odensky E, Lewis PE, Martinetti P. Efficacy trial of an internet-based intervention for cancer-related female sexual dysfunction. J Natl Compr Cancer Netw. 2013;11:1389\u201397.","journal-title":"J Natl Compr Cancer Netw"},{"key":"606_CR18","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.cct.2009.12.005","volume":"31","author":"DR Taves","year":"2010","unstructured":"Taves DR. The use of minimization in clinical trials. Contemp Clin Trials. 2010;31:180\u20134.","journal-title":"Contemp Clin Trials"},{"key":"606_CR19","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/00926230490422340","volume":"30","author":"RC Rosen","year":"2004","unstructured":"Rosen RC, Lobo RA, Block BA, Yang HM, Zipfel LM. Menopausal Sexual Interest Questionnaire (MSIQ): a unidimensional scale for the assessment of sexual interest in postmenopausal women. J Sex Marital Ther. 2004;30:235\u201350.","journal-title":"J Sex Marital Ther"},{"key":"606_CR20","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1743-6109.2007.00672.x","volume":"5","author":"L Derogatis","year":"2008","unstructured":"Derogatis L, Clayton A, Lewis-D\u2019Agostino D, Wunderlich G, Fu Y. Validation of the female sexual distress scale-revised for assessing distress in women with hypoactive sexual desire disorder. J Sex Med. 2008;5:357\u201364.","journal-title":"J Sex Med"},{"key":"606_CR21","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s10549-007-9682-9","volume":"109","author":"D Cella","year":"2008","unstructured":"Cella D, Land SR, Chang C-H, Day R, Costantino JP, Wolmark N, Ganz PA. Symptom measurement in the Breast Cancer Prevention Trial (BCPT) (P-1): psychometric properties of a new measure of symptoms for midlife women. Breast Cancer Res Treat. 2008;109:515\u201326.","journal-title":"Breast Cancer Res Treat"},{"issue":"S1","key":"606_CR22","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/geronb\/gbn021","volume":"64B","author":"ST Lindau","year":"2009","unstructured":"Lindau ST, Hoffmann JN, Lundeen K, Jaszczak A, McClintock MK, Jordan JA. Vaginal self-swab specimen collection in a home-based survey of older women: methods and applications. J Gerontol Social Sciences. 2009;64B(S1):106\u201318.","journal-title":"J Gerontol Social Sciences"},{"key":"606_CR23","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/10647440300025523","volume":"11","author":"S Roy","year":"2003","unstructured":"Roy S, Caillouette JC, Faden JS, Roy T, Ramos DE. Improving appropriate use of antifungal medications: the role of an over-the-counter vaginal pH self-test device. Infect Dis Obstet Gynecol. 2003;11:209\u201316.","journal-title":"Infect Dis Obstet Gynecol"},{"key":"606_CR24","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1111\/jsm.12125","volume":"10","author":"J Chen","year":"2013","unstructured":"Chen J, Geng L, Song X, Li H, Giordan N, Liao Q. Evaluation of the efficacy and safety of hyaluronic acid vaginal gel to ease vaginal dryness: a multicenter, randomized, controlled, open-label, parallel-group, clinical trial. J Sex Med. 2013;10:1575\u201384.","journal-title":"J Sex Med"},{"key":"606_CR25","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s00404-013-3068-5","volume":"288","author":"P Stute","year":"2013","unstructured":"Stute P. Is vaginal hyaluronic acid as effective as vaginal estriol for vaginal dryness relief? Arch Gynecol Obstet. 2013;288:1199\u2013201.","journal-title":"Arch Gynecol Obstet"},{"key":"606_CR26","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00404-010-1382-8","volume":"283","author":"M Ekin","year":"2011","unstructured":"Ekin M, Yasar L, Savan K, Temur M, Uhri M, Gencer I, K\u0131van\u00e7 E. The comparison of hyaluronic acid vaginal tablets with estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial. Arch Gynecol Obstet. 2011;283:539\u201343.","journal-title":"Arch Gynecol Obstet"},{"key":"606_CR27","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.radonc.2015.06.018","volume":"116","author":"E Law","year":"2015","unstructured":"Law E, Kelvin JF, Thom B, Riedel E, Tom A, Carter J, Alektiar KM, Goodman KA. Prospective study of vaginal dilator use adherence and efficacy following radiotherapy. Radiother Oncol. 2015;116:149\u201355.","journal-title":"Radiother Oncol"},{"key":"606_CR28","first-page":"CD007291","volume":"8","author":"T Miles","year":"2014","unstructured":"Miles T, Johnson N. Vaginal dilator therapy for women receiving pelvic radiotherapy. Cochrane Database Syst Rev. 2014;8:CD007291.","journal-title":"Cochrane Database Syst Rev"},{"key":"606_CR29","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/GME.0b013e31829e41df","volume":"21","author":"TK Kallak","year":"2014","unstructured":"Kallak TK, Baumgart J, G\u00f6ransson E, Nilsson K, Poromaa IS, Stavreus-Evers A. Aromatase inhibitors affect vaginal proliferation and steroid hormone receptors. Menopause. 2014;21:383\u201390.","journal-title":"Menopause"},{"key":"606_CR30","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.clbc.2015.06.012","volume":"15","author":"TK Kallak","year":"2015","unstructured":"Kallak TK, Baumgart J, Nilsson K, \u00c5kerud H, Poromaa IS, Stavreus-Evers A. Vaginal gene expression during treatment with aromatase inhibitors. Clin Breast Cancer. 2015;15:527\u201335.","journal-title":"Clin Breast Cancer"},{"key":"606_CR31","first-page":"110","volume":"4","author":"G Gandaglia","year":"2015","unstructured":"Gandaglia G, Suardi N, Cucchiara V, Bianchi M, Shariat SF, Roupret M, Salonia A, Montorsi F, Briganti A. Penile rehabilitation after radical prostatectomy: does it work? Transl Androl Urol. 2015;4:110\u201323.","journal-title":"Transl Androl Urol"},{"key":"606_CR32","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1111\/jsm.12457","volume":"11","author":"DR Meldrum","year":"2014","unstructured":"Meldrum DR, Burnett AL, Dorey G, Esposito K, Ignarro LJ. Erectile hydraulics: maximizing inflow while minimizing outflow. J Sex Med. 2014;11:1208\u201320.","journal-title":"J Sex Med"},{"key":"606_CR33","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/aja.2013.18","volume":"15","author":"HC Lin","year":"2013","unstructured":"Lin HC, Yang WL, Zhang JL, Dai YT, Wang R. Penile rehabilitation with a vacuum erectile device in an animal model is related to an antihypoxic mechanism: blood gas evidence. Asian J Androl. 2013;15:387\u201390.","journal-title":"Asian J Androl"},{"key":"606_CR34","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1111\/j.1743-6109.2010.01903.x","volume":"7","author":"AM Traish","year":"2010","unstructured":"Traish AM, Botchevar E, Kim NN. Biochemical factors modulating female genital sexual arousal physiology. J Sex Med. 2010;7:2925\u201346.","journal-title":"J Sex Med"},{"key":"606_CR35","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10549-012-2198-y","volume":"135","author":"I Le Ray","year":"2012","unstructured":"Le Ray I, Dell\u2019Aniello S, Bonnetain F, Azoulay L, Suissa S. Local estrogen therapy and risk of breast cancer recurrence among hormone-treated patients: a nested case-control study. Breast Cancer Res Treat. 2012;135:603\u20139.","journal-title":"Breast Cancer Res Treat"},{"key":"606_CR36","unstructured":"Committee Opinion No. 659. The use of vaginal estrogen in women with a history of estrogen-dependent breast cancer. Obstet Gynecol. 2016;127:393\u2013396."},{"key":"606_CR37","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s10549-014-2930-x","volume":"145","author":"G Donders","year":"2014","unstructured":"Donders G, Neven P, Moegele M, Lintermans A, Bellen G, Prasauskas V, Grob P, Ortmann O, Buchholz S. Ultra-low-dose estriol and lactobacillus acidophilus vaginal tablets (Gynoflor\u00ae) for vaginal atrophy in postmenopausal breast cancer patients on aromatase inhibitors: pharmacokinetic, safety, and efficacy phase I clinical study. Breast Cancer Res Treat. 2014;145:371\u20139.","journal-title":"Breast Cancer Res Treat"},{"key":"606_CR38","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1200\/JCO.2014.60.7366","volume":"33","author":"MF Goetsch","year":"2015","unstructured":"Goetsch MF, Lim JY, Caughey AB. A practical solution for dyspareunia in breast cancer survivors: a randomized controlled trial. J Clin Oncol. 2015;33:3394\u2013400.","journal-title":"J Clin Oncol"},{"key":"606_CR39","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1111\/jsm.12156","volume":"20","author":"I Juraskova","year":"2013","unstructured":"Juraskova I, Jarvis S, Mok K, Peate M, Meiser B, Cheah BC, Mireskandari S, Friedlander M. The acceptability, feasibility, and efficacy (phase l\/II study) of the OVERcome (olive oil, vaginal exercise, and moisturizer) intervention to improve dyspareunia and alleviate sexual problems in women with breast cancer. J Sex Med. 2013;20:2549\u201358.","journal-title":"J Sex Med"},{"key":"606_CR40","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/AOG.0b013e31828786f8","volume":"121","author":"JM Brown","year":"2013","unstructured":"Brown JM, Hess KL, Brown S, Murphy C, Waldman AL, Hezareh M. Intravaginal practices and risk of bacterial vaginosis and candidiasis infection among a cohort of women in the United States. Obstet Gynecol. 2013;121:773\u201380.","journal-title":"Obstet Gynecol"},{"key":"606_CR41","doi-asserted-by":"crossref","unstructured":"Mocellin S, Pilati P, Briarava M, Nitti D. Breast Cancer Chemoprevention: A Network Meta-Analysis of Randomized Controlled Trials. J Natl Cancer Inst. 2016;108.","DOI":"10.1093\/jnci\/djv318"},{"key":"606_CR42","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/pon.3520","volume":"23","author":"S Jennings","year":"2014","unstructured":"Jennings S, Philip EJ, Nelson C, Schuler T, Starr T, Jandorf L, Temple L, Garcia E, Carter J, DuHamel K. Barriers to recruitment in psycho-oncology: unique challenges in conducting research focusing on sexual health in female survivorship. Psychooncology. 2014;23:1192\u20135.","journal-title":"Psychooncology"}],"container-title":["Journal of Cancer Survivorship"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11764-017-0606-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-017-0606-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-017-0606-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,24]],"date-time":"2022-07-24T16:00:16Z","timestamp":1658678416000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11764-017-0606-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,22]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["606"],"URL":"https:\/\/doi.org\/10.1007\/s11764-017-0606-3","relation":{},"ISSN":["1932-2259","1932-2267"],"issn-type":[{"value":"1932-2259","type":"print"},{"value":"1932-2267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,22]]}}}